US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about TheraPsil

Recent news which mentions TheraPsil

Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More
Tickers ATAI CMPS CYBN DMTTF
Tags HUGE Psychedelics ENVB
From Benzinga
Canadian Practitioners Can Now Enroll In MDMA-Assisted Psychotherapy Training Program
Tags Psychedelics Management TheraPsil
From Benzinga
TheraPsil Unveils MDMA-Assisted Psychotherapy Training Program
Tags #Pharmaceuticals TheraPsil
From TheNewswire.com - RSS (Media)
Canadian Psychedelics Company And Nonprofit Team Up To Accelerate Access And Product Launch
Tickers LSDI
Tags Markets TheraPsil Market News
From Benzinga
Canada's Ongoing Struggle For Access To Natural Psilocybin As A Therapeutic Nabs Business Support
Tickers TRUFF
Tags Global Todd Shapiro Spencer Hawkswell
From Benzinga
Poll shows 80% of Canadians believe psilocybin mushrooms should be legal for medical purposes
Tags TheraPsil #Pharmaceuticals
From TheNewswire.com - RSS (Media)
Canada-Based Project Solace Aims To Provide Access And Data On Medical Psilocybin
Tags Benzinga News Cannabis
From Benzinga
Psyched: Cybin Debuts On NYSE, Nonprofits In Psychedelics Space Reach New Milestones, Filament Receives Psilocybin Patent
Tickers CYBN SILFF
Tags Usona Institute Small Cap SILFF
From Benzinga